What antihypertensive is least likely to affect heart rate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) are the antihypertensive medications least likely to affect heart rate. These medications work by blocking the renin-angiotensin-aldosterone system, which primarily affects blood vessel tone rather than cardiac output or heart rate 1. Common ACE inhibitors include lisinopril, enalapril, and ramipril, while common ARBs include losartan, valsartan, and olmesartan. Typical starting doses are lisinopril 10mg daily or losartan 50mg daily, which can be titrated up as needed for blood pressure control.

These medications effectively lower blood pressure by causing vasodilation and reducing peripheral resistance without directly affecting the sinoatrial node or cardiac conduction system. This makes them particularly useful in patients with bradycardia, tachycardia, or certain arrhythmias where maintaining the current heart rate is desirable. In contrast, beta-blockers and certain calcium channel blockers can significantly reduce heart rate as part of their mechanism of action. Diuretics and direct vasodilators also have minimal direct effects on heart rate, though they may cause reflex tachycardia in some patients.

Some key points to consider when choosing an antihypertensive medication include:

  • The ability of the medication to lower blood pressure without affecting heart rate
  • The presence of comorbid conditions, such as heart failure or diabetes
  • The potential for adverse effects, such as weight gain or dyslipidemia
  • The need for combination therapy to achieve adequate blood pressure control. According to the European guidelines on cardiovascular disease prevention in clinical practice, ACE inhibitors and ARBs are suitable for initiation and maintenance of antihypertensive treatment, either as monotherapy or in combination 1.

From the FDA Drug Label

In hemodynamic studies of lisinopril in patients with essential hypertension, blood pressure reduction was accompanied by a reduction in peripheral arterial resistance with little or no change in cardiac output and in heart rate.

The antihypertensive least likely to affect heart rate is lisinopril.

  • It has been shown to reduce blood pressure with little or no change in heart rate.
  • This effect is due to its mechanism of action, which involves reducing peripheral arterial resistance without significantly affecting cardiac output or heart rate 2.

From the Research

Antihypertensive Medications and Heart Rate

  • The antihypertensive medication least likely to affect heart rate is an ACE inhibitor, such as lisinopril 3, 4, 5.
  • Studies have shown that lisinopril does not significantly alter heart rate 3, 5.
  • In comparison, diuretics may increase heart rate, especially when combined with beta-blockers 4.
  • The ALLHAT trial found that lisinopril had a similar effect on heart rate as chlorthalidone, a diuretic, but with a slightly lower systolic blood pressure reduction 6.
  • Another study found that the addition of an ACE inhibitor to a beta-blocker did not significantly affect heart rate, whereas the addition of a diuretic increased heart rate 4.

Comparison of Antihypertensive Medications

  • ACE inhibitors, such as lisinopril, have been compared to diuretics, such as hydrochlorothiazide, in several studies 6, 4, 5, 7.
  • The results of these studies suggest that ACE inhibitors may be a good option for patients who require antihypertensive medication with minimal effects on heart rate 3, 4, 5.
  • However, the choice of antihypertensive medication should be individualized based on patient characteristics and medical history 6, 7.

Related Questions

What is the first-line anti-hypertensive medication, including dosage and frequency, for a 40-year-old woman with hypertension (high blood pressure), hyperprolactinemia (elevated prolactin levels), and normal thyroid function (normal T3 and T4 levels), presenting with a blood pressure of 160/90 mmHg?
What were the findings of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)?
What is the next step to manage a 68-year-old female patient with hypertension (HTN) whose blood pressure remains elevated at 158/110 mmHg despite recently increased lisinopril (angiotensin-converting enzyme inhibitor) to 40 mg?
What is the most appropriate initial antihypertensive agent for a black female patient with newly diagnosed hypertension (High Blood Pressure), history of cataracts, gout, and obstructive sleep apnea (OSA)?
What is the recommended initial antihypertensive medication for a patient with hypertension?
What is the most appropriate management for an 8-year-old girl with asthma, presenting with a rattling cough, wheeze, low-grade fever, and sore throat, who is currently wheezing, tachypneic, and has mild hypoxemia, despite recent albuterol (salbutamol) treatment via nebulizer?
Is a combination of acarbose, Ozempic (semaglutide), insulin, and Farxiga (dapagliflozin) acceptable for managing type 2 diabetes?
Clindamycin or Amoxicillin for tooth infection?
What are the next steps for a patient with vitamin B12 (cobalamin) deficiency who is unresponsive to cyanocobalamin injections?
Can the dose of nifedipine (Nifedipine) XR be increased for better blood pressure control?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.